Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPIRANT
2007-003558-27Phase 4Completed
- Sponsor
- University Hospital Olomouc
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in resistant hypertension (RH) comparing Spironolactone add-on with Placebo add-on (2 arms). Primary endpoint: Change in average daily systolic and diastolic blood pressure by ABPM. Started Jul 2007; status: completed.
02
Drugs
spironolactone
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on 2007-003558-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003558-27.